p38 mitogen-activated protein kinase regulates mitochondrial function and microvesicle release in riboflavin- and ultraviolet light–treated apheresis platelet concentrates

Transfusion

Volumn 57, Issue 5, 2017, Pages 1199-1207

  Chen, Zhongming ^a,b   Schubert, Peter ^a,b   Bakkour, Sonia ^c   Culibrk, Brankica ^a,b   Busch, Michael P ^c,d   Devine, Dana V ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOCHROME C; DIMETHYL SULFOXIDE; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BID; REACTIVE OXYGEN METABOLITE; RIBOFLAVIN; THROMBOCYTE CONCENTRATE;

ANIMAL CELL; APHERESIS; APOPTOSIS; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME REGULATION; FLOW CYTOMETRY; IMMUNOBLOTTING; MEMBRANE MICROPARTICLE; MITOCHONDRIAL MEMBRANE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE POLYMERASE CHAIN REACTION; ULTRAVIOLET RADIATION; DRUG EFFECTS; ENZYMOLOGY; HUMAN; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PHYSIOLOGY; PROCEDURES; RADIATION RESPONSE; SECRETION (PROCESS); SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOCYTOPHERESIS; ULTRASTRUCTURE;

BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; HUMANS; MAP KINASE SIGNALING SYSTEM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLATELETPHERESIS; REACTIVE OXYGEN SPECIES; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 85013793304     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14035     Document Type: Article

References (46)

1. Devine DV, Schubert P. Pathogen inactivation technologies: the advent of pathogen-reduced blood components to reduce blood safety risk. Hematol Oncol Clin North Am 2016;30:609-17.
2. Goodrich RP, Edrich RA, Li J, et al. The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006;35:5-17.
3. Schubert P, Devine DV. Proteomics meets blood banking: identification of protein targets for the improvement of platelet quality. J Proteomics 2010;73:436-44.
4. Reesink HW, Panzer S, McQuilten ZK, et al. Pathogen inactivation of platelet concentrates. Vox Sang 2010;99:85-95.
5. Gyulkhandanyan AV, Mutlu A, Freedman J, et al. Mitochondrial permeability transition pore (MPTP)-dependent and -independent pathways of mitochondrial membrane depolarization, cell shrinkage and microparticle formation during platelet apoptosis. Br J Haematol 2015;169:142-5.
6. Leytin V, Allen DJ, Mutlu A, et al. Mitochondrial control of platelet apoptosis: effect of cyclosporin A, an inhibitor of the mitochondrial permeability transition pore. Lab Invest 2009;89:374-84.
7. Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 2005;115:3348-54.
8. Schoenwaelder SM, Jackson SP. Bcl-xL-inhibitory BH3 mimetics (ABT-737 or ABT-263) and the modulation of cytosolic calcium flux and platelet function. Blood 2012;119:1320-1; author reply 1321-2.
9. Leytin V. Apoptosis in the anucleate platelet. Blood Rev 2012;26:51-63.
10. Mason KD, Carpinelli MR, Fletcher JI, et al. Programmed anuclear cell death delimits platelet life span. Cell 2007;128:1173-86.
11. Picker SM, Schneider V, Oustianskaia L, et al. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies. Transfusion 2009;49:2311-8.
12. Picker SM, Steisel A, Gathof BS. Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: results of a three-arm in vitro study. Transfus Apher Sci 2009;40:79-85.
13. Picker SM, Steisel A, Gathof BS. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. Transfusion 2008;48:1685-92.
14. Reid S, Johnson L, Woodland N, et al. Pathogen reduction treatment of buffy coat platelet concentrates in additive solution induces proapoptotic signaling. Transfusion 2012;52:2094-103.
15. Schubert P, Coupland D, Culibrk B, et al. Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment. Transfusion 2013;53:3164-73.
16. Krötz F, Sohn HY, Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 2004;24:1988-96.
17. Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008;4:89-96.
18. Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012;24:981-90.
19. Lopez JJ, Salido GM, Gómez-Arteta E, et al. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 2007;5:1283-91.
20. Johnson L, Marks D. Treatment of platelet concentrates with the Mirasol pathogen inactivation system modulates platelet oxidative stress and NF-κB activation. Transfus Med Hemother 2015;42:167-73.
21. Kumar V, Lockerbie O, Keil SD, et al. Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level. Photochem Photobiol 2004;80:15-21.
22. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004;23:2838-49.
23. Saklatvala J, Rawlinson L, Waller RJ, et al. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue. J Biol Chem 1996;271:6586-9.
24. Canault M, Duerschmied D, Brill A, et al. p38 mitogen-activated protein kinase activation during platelet storage: consequences for platelet recovery and hemostatic function in vivo. Blood 2010;115:1835-42.
25. Chen Z, Schubert P, Culibrk B, et al. p38MAPK is involved in apoptosis development in apheresis platelet concentrates after riboflavin and ultraviolet light treatment. Transfusion 2015;55:848-57.
26. Boudreau LH, Duchez AC, Cloutier N, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. Blood 2014;124:2173-83.
27. Lauring AS, Lee TH, Martin JN, et al. Lack of evidence for mtDNA as a biomarker of innate immune activation in HIV infection. PLoS One 2012;7:e50486.
28. Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 2007;47:143-83.
29. Skripchenko A, Awatefe H, Thompson-Montgomery D, et al. An inhibition of p38 mitogen activated protein kinase delays the platelet storage lesion. PLoS One 2013;8:e70732.
30. Lopez JJ, Salido GM, Pariente JA, et al. Thrombin induces activation and translocation of Bid, Bax and Bak to the mitochondria in human platelets. J Thromb Haemost 2008;6:1780-8.
31. Apel K, Hirt H. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu Rev Plant Biol 2004;55:373-99.
32. Wang Z, Cai F, Chen X, et al. The role of mitochondria-derived reactive oxygen species in hyperthermia-induced platelet apoptosis. PLoS One 2013;8:e75044.
33. Del Principe D, Menichelli A, De Matteis W, et al. Hydrogen peroxide has a role in the aggregation of human platelets. FEBS Lett 1985;185:142-6.
34. Feys HB, Van Aelst B, Devreese K, et al. Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion. Vox Sang 2014;106:307-15.
35. Rukoyatkina N, Mindukshev I, Walter U, et al. Dual role of the p38 MAPK/cPLA2 pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists. Cell Death Dis 2013;4:e931.
36. Zhao L, Lu G, Zhao Q, et al. Staurosporine induces platelet apoptosis through p38 mitogen-activated protein kinase signaling pathway. Clin Lab 2015;61:717-26.
37. Sadallah S, Eken C, Martin PJ, et al. Microparticles (ectosomes) shed by stored human platelets downregulate macrophages and modify the development of dendritic cells. J Immunol 2011;186:6543-52.
38. Nomura S, Okamae F, Abe M, et al. Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes. Clin Appl Thromb Hemost 2000;6:213-21.
39. Burnouf T, Chou ML, Goubran H, et al. An overview of the role of microparticles/microvesicles in blood components: are they clinically beneficial or harmful? Transfus Apher Sci 2015;53:137-45.
40. Krysko DV, Agostinis P, Krysko O, et al. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157-64.
41. Morel O, Jesel L, Freyssinet JM, et al. Cellular mechanisms underlying the formation of circulating microparticles. Arterioscler Thromb Vasc Biol 2010;31:15-26.
42. Vasina EM, Cauwenberghs S, Feijge MA, et al. Microparticles from apoptotic platelets promote resident macrophage differentiation. Cell Death Dis 2011;2:e211.
43. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010;464:104-7.
44. Yasui K, Matsuyama N, Kuroishi A, et al. Mitochondrial damage-associated molecular patterns as potential proinflammatory mediators in post-platelet transfusion adverse effects. Transfusion 2016;56:1201-12.
45. Cognasse F, Aloui C, Anh Nguyen K, et al. Platelet components associated with adverse reactions: predictive value of mitochondrial DNA relative to biological response modifiers. Transfusion 2016;56:497-504.
46. Bakkour S, Chafets DM, Wen L, et al. Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light. Vox Sang 2014;107:351-9.